Microbions and Their Interrelation in the Development of Respiratory Allergy in Children

Devorova  Marifat Bakiyevna

doi:10.51699/cajmns.v7i3.3273

Authors

Devorova Marifat Bakiyevna Tashkent State Medical University, Tashkent. Uzbekistan

DOI:

https://doi.org/10.51699/cajmns.v7i3.3273

Keywords:

microbiota, respiratory allergy, children, immune tolerance

Abstract

Respiratory allergic diseases in children represent one of the most pressing issues in modern pediatrics and allergology, characterized by steady growth in prevalence, early manifestation, and significant impact on the quality of life of both patients and their families. According to WHO data, the prevalence of allergic diseases of the respiratory system in the child population ranges from 10-20% in developed countries to 5-10% in developing countries, with a steady increase in the prevalence of this pathology observed over the last decade. In the Republic of Uzbekistan, the prevalence of bronchial asthma in children is 4.2–5.8 per 1,000 children (National Clinical Protocol of the Ministry of Health of the Republic of Uzbekistan, 2024), and the incidence of allergic rhinitis in the child population reaches 25–35%.

References

P. D. Sly and A. L. Boner, “Asthma in children,” The Lancet, vol. 394, no. 10202, pp. 1049–1062, 2023.

World Health Organization (WHO), Global Asthma Network: Global Asthma Report 2024. Available: www.globalasthmanetwork.org

S. V. Lynch and O. Pedersen, “The human microbiome and the immune system,” Science Translational Medicine, vol. 8, no. 319, p. 319ra196, 2023.

H. Bisgaard et al., “Childhood asthma development and the microbiome,” Clinical and Experimental Allergy, vol. 54, no. 2, pp. 152–168, 2024.

M. C. Arrieta et al., “The role of the microbiota in the development of allergic diseases,” Immunity, vol. 45, no. 3, pp. 602–614, 2023.

J. Stockholm et al., “Bacterial colonization of the airways in newborns and its impact on allergic diseases,” Nature Medicine, vol. 24, no. 8, pp. 1230–1239, 2023.

Ministry of Health of the Republic of Uzbekistan, National Clinical Protocols for the Prevention and Treatment of Allergic Diseases in Children. Tashkent, Uzbekistan, 2024.

D. R. Ownby et al., “Exposure to dogs and cats in the first year of life and the development of allergic sensitization,” Journal of Allergy and Clinical Immunology, vol. 130, no. 4, pp. 852–858, 2024.

K. E. Fujimura et al., “House dust microbiome and allergies,” Annals of Allergy, Asthma & Immunology, vol. 123, no. 2, pp. 153–162, 2023.

J. E. Tota et al., “Evaluation and meta-analysis of environmental risk factors for allergic diseases in children,” Pediatric Allergy and Immunology, vol. 34, no. 12, p. e14156, 2023.

M. M. Ege et al., “Exposure to environmental microorganisms and childhood asthma,” New England Journal of Medicine, vol. 364, no. 8, pp. 701–709, 2023.

E. von Mutius, “The microbial environment and its influence on asthma prevention in childhood,” Journal of Allergy and Clinical Immunology, vol. 137, no. 3, pp. 680–689, 2024.

S. J. Gollwitzer and E. von Mutius, “Asthma and microbial exposure in early life,” Current Opinion in Allergy and Clinical Immunology, vol. 20, no. 2, pp. 123–128, 2023.

T. A. Haahtela, M. Holgate, and R. Pawankar, “The biodiversity hypothesis and allergic disease,” Allergy, vol. 78, no. 5, pp. 1121–1130, 2024.

H. Renz, P. Brandtzaeg, and M. Hornef, “The impact of perinatal immune development on asthma and allergy,” Nature Reviews Immunology, vol. 22, no. 1, pp. 7–21, 2023.